Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,613 | 1,732 | 1,863 | 1,973 | 1,648 |
| Income taxes - deferred | -177 | -97 | 7,113 | -1,433 | -1,719 |
| Accounts receivable | -210 | 509 | 7,803 | -338 | -4,981 |
| Other Working Capital | 323 | 830 | 2,200 | 5,636 | -1,425 |
| Other Operating Activity | 3,784 | 897 | -12,126 | 4,556 | 9,272 |
| Operating Cash Flow | $5,333 | $3,870 | $6,853 | $10,395 | $2,794 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -187 | -223 | -339 | -572 | -594 |
| Sale Of Investment | -5 | 165 | -6 | N/A | N/A |
| Other Investing Activity | 48 | 46 | 114 | 549 | 0 |
| Investing Cash Flow | $-144 | $-12 | $-231 | $-23 | $-594 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -32 | -114 | N/A |
| Common Stock Repurchased | N/A | N/A | -107 | N/A | N/A |
| Dividend Paid | -1,112 | -1,188 | -5,222 | -1,314 | -1,171 |
| Other Financing Activity | -638 | 0 | 69 | -274 | -98 |
| Financing Cash Flow | $-1,750 | $-1,188 | $-5,291 | $-1,702 | $-1,270 |
| Exchange Rate Effect | 28 | 12 | 2 | 1 | 0 |
| Beginning Cash Position | 27,215 | 24,533 | 23,918 | 14,763 | 14,114 |
| End Cash Position | 29,874 | 27,215 | 25,091 | 23,918 | 14,763 |
| Net Cash Flow | $3,440 | $2,670 | $1,331 | $8,669 | $931 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,333 | 3,870 | 6,853 | 10,395 | 2,794 |
| Capital Expenditure | -187 | -223 | -340 | -572 | -594 |
| Free Cash Flow | 5,147 | 3,647 | 6,513 | 9,823 | 2,200 |